BiVictriX Therapeutics plc (BVX) Ord GBP0.01

- Add to watchlist
- Create an alert
- This stock can be held in a




11.00p
11.50p
19.20p
£9.08 million
11.00p
11.00p
9.00p
n/a
0.00p (0.00%) Previous:
0.00p
100,000
n/a
7,500
Performance
1 week 1W | 0% | 1 year 1Y | 29.03% |
---|---|---|---|
1 month 1M | 15.38% | 2 years 2Y | 54.17% |
3 months 3M | 24.14% | 3 years 3Y | n/a |
6 months 6M | 18.52% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | n/a | n/a |
Profit before tax (£m) | (2.97) | (2.53) |
Adjusted EPS (p): | (3.78) | (6.02) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
BiVictriX gets patent for its lead asset in Japan
15 November 2023 12:55
-
BiVictriX posts promising preclinical data on leukaemia candidate
12 October 2023 13:44
-
BiVictriX appoints Adrian Howd as its new finance chief
3 October 2023 10:14
-
Board Change
5 December 2023 11:08
-
Pipeline update on BVX002
30 November 2023 07:00
-
Holding(s) in Company
22 November 2023 17:14
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Annual & interim reports
Annual & interim reports are not available for this stock.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.